Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACRAuthor links open overlay panelDebra L. Monticciolo MD a, Mary S. Newell MD b, Linda Moy MD c, Bethany Niell MD, PhD d, Barbara Monsees MD e...
Breast cancer screening recommendations for transgender and gender nonconforming individuals are based on the sex assigned at birth, risk factors, and use of exogenous hormones. Insufficient evidence exists to determine whether transgender people undergoing hormone therapy have an overall lower, average, ...
Although recall and biopsy recommendations are higher with more frequent screening, so are life-years gained and breast cancer deaths averted. Women who wish to maximize bene?t will choose annual screening starting at age 40 years and will not stop screening prematurely. Key Words: Breast cancer,...
Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasou... Screening for breast cancer with mammography has been shown to decrease mortality from breast cancer, and mammography is the mainstay of ...
2016+ACR适宜性标准：乳腺癌筛查 ORIGINAL ARTICLE ACR Appropriateness Criteria Breast Cancer Screening Martha B.Mainiero,MD a,Ana Lourenco,MD a,Mary C.Mahoney,MD b,Mary S.Newell,MD c, Lisa Bailey,MD d,e,Lora D.Barke,DO f,Carl D’Orsi,MD c,Jennifer A.Harvey,MD g,Mary K.Hayes,MD h,...
Breast Cancer Screening Should Begin At Age 40 According To New SBI And ACR RecommendationsHeather Curry
Screening for disease using imaging technologies is a growing phenomenon. For some applications (e.g., mammography and breast cancer), there is solid evidence that imaging screening reduces disease-specific mortality. However, for other applications, the public interest in imaging screening is ...
ScreeningbreastcancerrecommendationsmammographybreastultrasoundbreastMRIScreening for breast cancer with mammography has been shown to decrease mortality from breast cancer, and mammography is the mainstay of screening for clinically occult disease. Mammography, however, has well-recognized limitations, and ...
Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be considered based on the patient's risk level and breast ...
This "classification ACR" is adapted from BI-RADS but strongly influenced by the context of the French nationwide screening programme, and by European recommendations to limitate undesirable risks of screening such as false positive and overdiagnosis. The differences between the two systems are ...